JP2024069459A5 - - Google Patents

Download PDF

Info

Publication number
JP2024069459A5
JP2024069459A5 JP2024039768A JP2024039768A JP2024069459A5 JP 2024069459 A5 JP2024069459 A5 JP 2024069459A5 JP 2024039768 A JP2024039768 A JP 2024039768A JP 2024039768 A JP2024039768 A JP 2024039768A JP 2024069459 A5 JP2024069459 A5 JP 2024069459A5
Authority
JP
Japan
Prior art keywords
vial
asmd
lyophilized composition
moisture
human patient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2024039768A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024069459A (ja
JP7832245B2 (ja
Filing date
Publication date
Priority claimed from JP2020565415A external-priority patent/JP7497300B2/ja
Application filed filed Critical
Publication of JP2024069459A publication Critical patent/JP2024069459A/ja
Publication of JP2024069459A5 publication Critical patent/JP2024069459A5/ja
Priority to JP2026033801A priority Critical patent/JP2026086903A/ja
Application granted granted Critical
Publication of JP7832245B2 publication Critical patent/JP7832245B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2024039768A 2018-05-25 2024-03-14 酸性スフィンゴミエリナーゼ欠損症を治療するための医薬組成物 Active JP7832245B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2026033801A JP2026086903A (ja) 2018-05-25 2026-03-04 酸性スフィンゴミエリナーゼ欠損症を治療するための医薬組成物

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201862676525P 2018-05-25 2018-05-25
US62/676,525 2018-05-25
JP2020565415A JP7497300B2 (ja) 2018-05-25 2019-05-24 酸性スフィンゴミエリナーゼ欠損症を治療するための医薬組成物
PCT/US2019/033983 WO2019227029A1 (en) 2018-05-25 2019-05-24 Pharmaceutical compositions for treating acid sphingomyelinase deficiency

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2020565415A Division JP7497300B2 (ja) 2018-05-25 2019-05-24 酸性スフィンゴミエリナーゼ欠損症を治療するための医薬組成物

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2026033801A Division JP2026086903A (ja) 2018-05-25 2026-03-04 酸性スフィンゴミエリナーゼ欠損症を治療するための医薬組成物

Publications (3)

Publication Number Publication Date
JP2024069459A JP2024069459A (ja) 2024-05-21
JP2024069459A5 true JP2024069459A5 (cg-RX-API-DMAC10.html) 2025-04-04
JP7832245B2 JP7832245B2 (ja) 2026-03-17

Family

ID=66912954

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2020565415A Active JP7497300B2 (ja) 2018-05-25 2019-05-24 酸性スフィンゴミエリナーゼ欠損症を治療するための医薬組成物
JP2024039768A Active JP7832245B2 (ja) 2018-05-25 2024-03-14 酸性スフィンゴミエリナーゼ欠損症を治療するための医薬組成物
JP2026033801A Pending JP2026086903A (ja) 2018-05-25 2026-03-04 酸性スフィンゴミエリナーゼ欠損症を治療するための医薬組成物

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2020565415A Active JP7497300B2 (ja) 2018-05-25 2019-05-24 酸性スフィンゴミエリナーゼ欠損症を治療するための医薬組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2026033801A Pending JP2026086903A (ja) 2018-05-25 2026-03-04 酸性スフィンゴミエリナーゼ欠損症を治療するための医薬組成物

Country Status (15)

Country Link
US (1) US20210145941A1 (cg-RX-API-DMAC10.html)
EP (1) EP3802805A1 (cg-RX-API-DMAC10.html)
JP (3) JP7497300B2 (cg-RX-API-DMAC10.html)
KR (1) KR102852946B1 (cg-RX-API-DMAC10.html)
CN (1) CN112424347A (cg-RX-API-DMAC10.html)
AU (2) AU2019275109C1 (cg-RX-API-DMAC10.html)
BR (1) BR112020023829A2 (cg-RX-API-DMAC10.html)
CA (1) CA3101688A1 (cg-RX-API-DMAC10.html)
CO (1) CO2020014399A2 (cg-RX-API-DMAC10.html)
IL (1) IL278964A (cg-RX-API-DMAC10.html)
MX (2) MX2020012700A (cg-RX-API-DMAC10.html)
PY (1) PY1939780A (cg-RX-API-DMAC10.html)
SG (1) SG11202011488WA (cg-RX-API-DMAC10.html)
UY (1) UY38238A (cg-RX-API-DMAC10.html)
WO (1) WO2019227029A1 (cg-RX-API-DMAC10.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2022214529A1 (en) * 2021-02-01 2023-08-03 The Trustees Of The University Of Pennsylvania Compositions and methods for treatment of niemann pick type a disease
TW202403043A (zh) * 2022-03-18 2024-01-16 美商健臻公司 重組人類酸性鞘磷脂酶醫藥組合物及方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5773278A (en) 1991-05-03 1998-06-30 Mount Sinai Medical Center Acid sphingomyelinase gene
CA2466054C (en) 2001-11-13 2012-01-03 Genentech, Inc. Apo-2 ligand/trail formulations
WO2004112826A1 (en) * 2003-06-20 2004-12-29 Ares Trading Sa Freeze-dried fsh / lh formulations
CN1897957A (zh) * 2003-11-25 2007-01-17 纽约大学西奈山医学院 尼曼-皮克病的基于陪伴分子的治疗
AR059089A1 (es) * 2006-01-20 2008-03-12 Genzyme Corp Administracion intraventricular de una enzima para enfermedades de almacenamiento lisosomal
ES2391657T3 (es) * 2006-02-07 2012-11-28 Shire Human Genetic Therapies, Inc. Composiciones estabilizadas de proteínas que tienen un resto tiol libre
BRPI0708879A2 (pt) * 2006-03-13 2011-06-14 Encysive Pharmaceuticals peocessos e composiÇÕes para o tratamento de insufiÊncia cardÍaca diastàlica
AU2007226582B2 (en) * 2006-03-13 2012-07-05 Revvity Health Sciences, Inc. Substrates and internal standards for mass spectroscopy detection
MX2011013722A (es) * 2009-06-18 2012-05-08 Wyeth Llc Formulaciones liofilizadas para inmunofarmaceuticos modulares pequeños.
CA2773133A1 (en) 2009-08-28 2011-03-03 Edward H. Schuchman Dose escalation enzyme replacement therapy for treating acid sphingomyelinase deficiency
JP6073783B2 (ja) * 2010-06-25 2017-02-01 シャイアー ヒューマン ジェネティック セラピーズ インコーポレイテッド ヘパランn−スルファターゼのcns送達のための方法および組成物
MX338436B (es) 2011-03-31 2016-04-18 Medy Tox Inc Preparacion liofilizada de toxinas de botulismo.
JP6480154B2 (ja) * 2014-11-06 2019-03-06 持田製薬株式会社 エタネルセプトの凍結乾燥製剤
FI126979B (en) * 2016-02-29 2017-09-15 Faron Pharmaceuticals Oy Lyophilized pharmaceutical formulation and its use
PL3672622T3 (pl) * 2017-08-24 2024-04-02 Genzyme Corporation Rekombinowana ludzka kwaśna sfingomielinaza do zastosowania w leczeniu nieprawidłowych stanów kości u pacjentów z niedoborem kwaśnej sfingomielinazy

Similar Documents

Publication Publication Date Title
US4289750A (en) Therapy of conditions which may be associated with altered renal function and dosage forms therefor
Greco et al. Hydrofluoric acid-induced hypocalcemia
Ropper et al. Limited relapse in Guillain-Barré syndrome after plasma exchange
CA2288143A1 (en) Activated protein c formulations
US7429377B2 (en) Therapeutic composition containing a plurality of immobilized proteases
JP2020108787A (ja) 消化管感染症に対する管腔内治療システム
Kumar et al. Bisphosphonate-related osteonecrosis of the jaws: a report of three cases demonstrating variability in outcomes and morbidity
US20090182055A1 (en) Fungicidal agent containing n-chlorotaurine and use thereof
CN107802645A (zh) 稀土元素喷剂
SE536581C2 (sv) Ett kit för behandling av sår eller liknande och ett preparat och metoder därav
JP2021525083A5 (cg-RX-API-DMAC10.html)
Paterson et al. Severe disseminated staphylococcal disease associated with osteitis and septic arthritis
JPH0222223A (ja) 医薬組成物
ES2312421T3 (es) Composicion farmaceutica en gel.
EP0074426A1 (en) Pharmaceutical oral dosage forms of an active agent capable of forming or releasing bicarbonate ions
EP4302787B1 (en) Hydroxyethycellulose gel compositions comprising bacteriophages
ES2962272T3 (es) Agentes para su uso en estados inflamatorios de las mucosas
TWI773927B (zh) 促進及治療慢性傷口癒合之組合物及方法
US7790928B1 (en) Therapeutic dimethyl sulfoxide (aka DMSO) compositions and methods of use
Porat et al. Complications of suppurative arthritis and osteomyelitis in children
ES2331461T3 (es) Composiciones para el tratamiento de la hemorragia con un factor activo viia y fibrinogeno.
Jimenez-Shehab et al. Oral cefadroxil in the treatment of bone and joint infections in children and adults
CN105709140A (zh) 一种治疗过敏性肺炎的药物组合物及其制备方法
Noble et al. Use of a trypsin, Peru balsam, and castor oil spray on the oral mucosa: case report and review of the literature
RU2005487C1 (ru) Способ лечения бронхолегочных заболеваний